Business

VB holdings could represent 24% upside potential

ProDentim

[ad_1]

Looking at the underlying ETF holdings in our coverage universe on ETF Channel, we compared the trading price of each holding to the 12-month futures analyst average target price, and calculated the weighted average implied analyst target price. for the ETF itself. For the Vanguard Small-Cap ETF (Symbol: VB), we found that the analysts’ implied target price for the ETF based on its underlying holdings is $223.87 per share.

With VB trading at a recent price close to $179.97 per share, this means analysts see 24.39% upside potential for this ETF when looking at the average analyst targets of the underlying holdings. Three of VB’s underlying holdings with a notable advantage over their analyst target prices are Latham Group Inc (Symbol: SWIM), Coursera Inc (Symbol: COUR) and Alignment Healthcare Inc (Symbol: ALHC). Although SWIM traded at a recent price of $3.15/share, the average analyst target is 76.57% higher at $5.56/share. Similarly, COUR is up 74.69% from the recent stock price of $11.22 if the average analyst target price of $19.60/share is reached, and analysts expect average for the ALHC to reach a target price of $19.39/share, which is 71.12% above the recent price of $11.33. Below is a 12 month price history chart comparing the performance of SWIM, COUR and ALHC stocks:

Table of relative performance SWIM, COUR and ALHC


Below is a table summarizing the current target prices of the analysts mentioned above:

Last name Symbol Recent Price Avg. 12-MB Analyst. Target % increase over target
Vanguard Small Cap ETF VB $179.97 $223.87 24.39%
Latham Group Inc. SWIM $3.15 $5.56 76.57%
Coursera Inc. COURT $11.22 $19.60 74.69%
Alignment Health Inc ALHC $11.33 $19.39 71.12%

Are analysts justified in these targets, or too optimistic about where these stocks will trade in 12 months? Do the analysts have a valid rationale for their goals, or are they lagging behind recent company and industry developments? A high price target relative to a stock’s price can reflect optimism about the future, but can also be a precursor to target price declines if targets were a relic of the past. These are questions that require further investor research.

10 ETFs with the Most Benefits for Analyst Goals »

Also see:

• Industrial equity hedge funds are buying
• AUID Year-to-Date Performance
• Institutional holders of PMCS

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

[ad_2]

nasdaq

alpilean
Back to top button